Cargando…

lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease

Long noncoding RNAs (lncRNAs) are potential regulators of a variety of cardiovascular diseases. Therefore, there is a series of differentially expressed lncRNAs in pulmonary arterial hypertension (PAH) that may be used as markers to diagnose PAH and even predict the prognosis. However, their specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qi, Fan, Wei, Lai, Banghui, Liao, Bin, Deng, Mingbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997923/ https://www.ncbi.nlm.nih.gov/pubmed/36893166 http://dx.doi.org/10.1371/journal.pone.0281061

Ejemplares similares

LncRNA TCONS_00004099-derived microRNA regulates oncogenesis through PTPRF in gliomas
por: Wang, Yuhao, et al.
Publicado: (2021)

Exosome-Derived LncRNA TCONS_00072128 Mediated Osteogenic Differentiation and Inflammation by Caspase 8 Regulation
por: Yang, Yongchang, et al.
Publicado: (2022)

Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer
por: Zhou, Xiaochen, et al.
Publicado: (2018)

A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1
por: Yu, Songman, et al.
Publicado: (2018)

LncRNA‐TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR‐143‐5p
por: Jin, Xuejing, et al.
Publicado: (2017)

LncRNA-TCONS_00034812 is upregulated in atherosclerosis and upregulates miR-21 through methylation in vascular smooth muscle cells
por: Lin, Dongsheng, et al.
Publicado: (2021)

LncRNA TCONS_00323213 Promotes Myogenic Differentiation by Interacting with PKNOX2 to Upregulate MyoG in Porcine Satellite Cells
por: Li, Mengxun, et al.
Publicado: (2023)

LncRNA TCONS_00021861 is functionally associated with drought tolerance in rice (Oryza sativa L.) via competing endogenous RNA regulation
por: Chen, Jiajia, et al.
Publicado: (2021)

Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease
por: Schuuring, M. J., et al.
Publicado: (2011)

MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

LncRNA TCONS_00023297 Regulates the Balance of Osteogenic and Adipogenic Differentiation in Bone Marrow Mesenchymal Stem Cells and the Coupling Process of Osteogenesis and Angiogenesis
por: Wang, Haitao, et al.
Publicado: (2021)

Relationship among porcine lncRNA TCONS_00010987, miR-323, and leptin receptor based on dual luciferase reporter gene assays and expression patterns
por: Ding, Yueyun, et al.
Publicado: (2020)

LncRNA TCONS_00145741 Knockdown Prevents Thrombin-Induced M1 Differentiation of Microglia in Intracerebral Hemorrhage by Enhancing the Interaction Between DUSP6 and JNK
por: Wu, Lanxiang, et al.
Publicado: (2022)

Healthcare status of adults with pulmonary hypertension due to congenital heart disease
por: Busse, Amely J., et al.
Publicado: (2022)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

Identification and verification of atrial fibrillation hub genes caused by primary mitral regurgitation
por: Yang, Qi, et al.
Publicado: (2023)

Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease
por: Blok, I.M., et al.
Publicado: (2015)

Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review
por: Varela, Daniel L, et al.
Publicado: (2018)

A Cardiac Arrest Case due to Left Coronary Artery Compression in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
por: Chida-Nagai, Ayako, et al.
Publicado: (2022)

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
por: Xu, Zhuoyuan, et al.
Publicado: (2021)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease
por: Condliffe, R., et al.
Publicado: (2018)

The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Carcinoembryonic antigen levels are increased with pulmonary output in pulmonary hypertension due to congenital heart disease
por: Zi-yang, Yang, et al.
Publicado: (2020)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
por: Lopes, Antonio, et al.
Publicado: (2014)

Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan
por: Schuuring, Mark J, et al.
Publicado: (2010)

Effect of Dexmedetomidine on Pulmonary Artery Pressure in Children with Congenital Heart Disease and Pulmonary Hypertension
por: Kanchi, Muralidhar, et al.
Publicado: (2020)

The lncRNA TCONS_00021785/miR-21-5p/Trim33 axis regulates VMP1-mediated zymophagy, reduces the activation of trypsinogen, and promotes acinar cell recovery
por: Wang, Qiang, et al.
Publicado: (2022)

Comparative transcription profiling of mRNA and lncRNA in pulmonary arterial hypertension after C75 treatment
por: Hou, Cuilan, et al.
Publicado: (2023)

Pulmonary hypertension in congenital heart disease
por: Pascall, Emma, et al.
Publicado: (2018)

LncRNAs ENST00000499459 and TCONS_00004989 enhance asthma progression in children with house dust mite-induced allergic asthma
por: Xude, Zhang, et al.
Publicado: (2022)

Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease
por: Çiftel, Murat, et al.
Publicado: (2012)

Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension
por: Swinnen, Katleen, et al.
Publicado: (2023)

Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases
por: Zhang, Xi, et al.
Publicado: (2016)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era
por: Schuuring, M. J., et al.
Publicado: (2011)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vjrv94had2ucordm8d94d4ofdn